Department of Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH, United States.
Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States.
J Clin Anesth. 2017 Dec;43:33-38. doi: 10.1016/j.jclinane.2017.09.005. Epub 2017 Sep 30.
The use of neuromuscular blockade agents (NMBA), had been associated with significant residual post-operative paralysis and morbidity. There is a lack of clinical evidence on incidence of postoperative complications within the post-anesthesia care unit (PACU) in patients exposed to intraoperative NMBA's. This study aims to estimate the incidence of post-operative complications associated with use of NMBAs and assessing its association with healthcare resource utilization.
Retrospective cohort.
Post-anesthesia care unit in tertiary care center.
Adults having non-cardiac surgery and receiving NMBAs between April-2005 and December-2013 MEASUREMENTS: We assessed: 1) incidences of major and minor PACU complications, 2) incidence of any postoperative complication in patients receiving a NMBA reversal (neostigmine) vs. without. 3) We secondarily assessed the relationship between PACU complications and use of healthcare resources.
The incidence of any major complications was 2.1% and that of any minor complication was 35.2%. ICU admission rate was 1.3% in patients without any complications, versus 5.2% in patients with any minor and 30.6% in patients with any major complication. ICU length of stay was prolonged in patients with any major (52.1±203h), compared to patients with any minor (6.2±64h) and with no complications (1.7±28h). Patients who received a NMBA and neostigmine, compared to without neostigmine, had a lower incidence of any major complication (1.7% vs. 6.05%), rate of re-intubation (0.8% vs. 4.6%) and unplanned ICU admission (0.8% vs. 3.2%).
This study documents that incidence of major PACU complications after non-cardiac surgery was 2.1%, with the most frequent complications being re-intubation and ICU admission. Patients receiving NMBA reversal were at a lower risk of re-intubation and unplanned ICU admission, justifying routine use of reversals. Complete NMBA reversals are crucial in reducing preventable patient harm and healthcare utilization.
神经肌肉阻滞剂(NMBA)的使用与术后显著的残余瘫痪和发病率有关。在接受术中 NMBA 的患者中,术后并发症在麻醉后护理单元(PACU)内的发生率缺乏临床证据。本研究旨在评估与 NMBA 使用相关的术后并发症的发生率,并评估其与医疗保健资源利用的关系。
回顾性队列研究。
三级保健中心的麻醉后护理单元。
接受非心脏手术并接受 NMBA 的成年人,时间为 2005 年 4 月至 2013 年 12 月。
我们评估了:1)PACU 主要和次要并发症的发生率,2)接受 NMBA 逆转(新斯的明)与不接受 NMBA 逆转的患者中任何术后并发症的发生率。3)我们还评估了 PACU 并发症与医疗资源使用之间的关系。
任何主要并发症的发生率为 2.1%,任何次要并发症的发生率为 35.2%。无并发症的患者 ICU 入住率为 1.3%,而有任何轻微并发症的患者为 5.2%,有任何主要并发症的患者为 30.6%。任何主要并发症患者的 ICU 住院时间延长(52.1±203h),与任何轻微并发症患者(6.2±64h)和无并发症患者(1.7±28h)相比。与未接受新斯的明的患者相比,接受 NMBA 和新斯的明的患者任何主要并发症的发生率较低(1.7% vs. 6.05%),再次插管的发生率(0.8% vs. 4.6%)和计划外 ICU 入院率(0.8% vs. 3.2%)。
本研究记录了非心脏手术后 PACU 主要并发症的发生率为 2.1%,最常见的并发症是再次插管和 ICU 入院。接受 NMBA 逆转的患者再次插管和计划外 ICU 入院的风险较低,证明常规使用逆转是合理的。完全逆转 NMBA 对于减少可预防的患者伤害和医疗保健利用至关重要。